O
Opthea Limited D
D
OPT
3.99000
USD
0.28
(7.55%)
مغلق
حجم التداول
640
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
614,008,440
المقالات
العنوان: Opthea Limited
القطاع: Healthcare
الصناعة: Biotechnology
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.